Trials / Not Yet Recruiting
Not Yet RecruitingNCT06352554
Susceptibility Testing In Neisseria Gonorrhoeae (STING) Study, Assessing the Performance of a New Rapid Test for Gonorrhoea Antibiotic Resistance, in a Cohort of 100 Culture Positive Neisseria Gonorrhoeae Infections
Susceptibility Testing In Neisseria Gonorrhoeae (STING) Study
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- SpeeDx Pty Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study aims to validate a novel antibiotic susceptibility test (InSignia) for gonorrhoea in patient clinical samples. The hypothesis is that the InSignia test will be able to detect transcriptional responses after incubation in antibiotic for susceptible strains and not resistant strains. Furthermore, this study will also add to our understanding on the performance of this test in various clinical specimens.
Conditions
Timeline
- Start date
- 2024-04-08
- Primary completion
- 2024-12-30
- Completion
- 2025-01-30
- First posted
- 2024-04-08
- Last updated
- 2024-04-09
Source: ClinicalTrials.gov record NCT06352554. Inclusion in this directory is not an endorsement.